form8k111209.htm
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):
November 12, 2009

 
MERIDIAN BIOSCIENCE, INC.
(Exact name of registrant as specified in its charter)

Ohio
  
0-14902
  
31-0888197
(State or other jurisdiction of incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No. )
 
 

3471 River Hills Drive, Cincinnati, Ohio
  
45244
(Address of principal executive offices)
  
(Zip Code)

 
 
Registrant’s telephone number, including area code
  
(513) 271-3700
 
 
 
 
 
(Former name or former address, if changed since last report.)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




 
 
Item 2.02.  Results of Operations and Financial Condition.

On November 12,  2009, the Registrant issued a press release announcing announcing its financial results for the fiscal year ended September 30, 2009.  A copy of the press release is furnished as Exhibit 99 to this report and is incorporated herein by reference.
 
Item 9.01.      Financial Statements and Exhibits.
 
 
(d)
 
Exhibits:
 
          The following exhibit is filed with this Current Report on Form 8-K:
 
  
Exhibit No.
Description
       
 
 99
  
Press Release dated November 12, 2009.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MERIDIAN BIOSCIENCE, INC.
 
 
  
       
Date:  November 13, 2009
By:
/s/ Melissa A. Lueke  
    Melissa A. Lueke  
    Vice President and Chief Financial Officer  
    (Principal Accounting Officer)